Ultrasound assessment of the essure contraceptive devices

Is three-dimensional ultrasound really needed?

Dario Paladini, Attilio Di Spiezio Sardo, Carmela Coppola, Brunella Zizolfi, Gaetano Pastore, Carmine Nappi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Study Objective: To evaluate the feasibility of 3-dimensional ultrasound (3DUS) for sonographic localization of Essure microinserts, comparing it with 2-dimensional ultrasound (2DUS) insofar as time to visualize the inserts and accuracy in determining their localization. Design: Prospective study (Canadian Task Force classification II-2). Setting: University clinic. Patients: Twenty-seven consecutive women undergoing hysteroscopic Essure device placement. Interventions: Essure microinserts were inserted in the outpatient hysteroscopy clinic following the manufacturer's recommendations, leaving from 3 to 8 loops of the inserts in the uterine cavity. In all patients, 2DUS and 3DUS were performed 3months after the procedure. 2DUS was performed first; the device(s) were located, and their position was recorded. Then 3DUS scans were acquired, trying when possible to have both devices at least at a 45-degree angle withthe insonation beam for optimal rendering on 3DUS. The OmniView method with volume contrast imaging was used to show the relationships of the microinserts within the uterine cavity when possible. To define the position of the Essure device in relation to the uterus and the salpinges, we used the classification developed by Legendre and colleagues. After sonographic evaluation all women underwent hysterosalpingography to assess the success of sterilization. Measurements and Main Results: Hysteroscopic insertion was successful in all patients, with 2 Essure devices placed in 25 patients and 1 device in 2 patients (due to previous salpingectomy performed because of ectopic pregnancy), for a total of 52 devices. One spontaneous late (within 3months) expulsion of the device occurred; the device had migrated almost completely into the uterine cavity. At 3-month follow-up, all 51 correctly placed devices were easily observed at 2DUS (mean [SD] duration of the procedure, 2.25 [0.8] minutes). At 3DUS in 51 cases, the device was in perfect position (1+2+3) in 21 (41.2%), in position 2+3 in 14 (27.4%), and in position +3 in 16 (31.4%). Both microinserts were observed on 3DUS reconstructed images in 31 of 35 (88.6%) 1+2+3 and 2+3 cases. However, in the 16 cases in which the devices were in position +3 (salpinx only), a single 3D sweep failed to demonstrate both devices in 10 of 16 cases (62.5%), due to substantially different angles of orientation of the inserts. This was because if 1 of the 2 devices was placed at a

Original languageEnglish
Pages (from-to)115-121
Number of pages7
JournalJournal of Minimally Invasive Gynecology
Volume22
Issue number1
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Contraceptive Devices
Equipment and Supplies
Fallopian Tubes
Salpingectomy
Hysterosalpingography
Hysteroscopy
Ectopic Pregnancy

Keywords

  • Essure microinserts
  • Hysteroscopy
  • Three-dimensional ultrasound
  • Two-dimensional ultrasound

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Medicine(all)

Cite this

Ultrasound assessment of the essure contraceptive devices : Is three-dimensional ultrasound really needed? / Paladini, Dario; Di Spiezio Sardo, Attilio; Coppola, Carmela; Zizolfi, Brunella; Pastore, Gaetano; Nappi, Carmine.

In: Journal of Minimally Invasive Gynecology, Vol. 22, No. 1, 01.01.2015, p. 115-121.

Research output: Contribution to journalArticle

Paladini, Dario ; Di Spiezio Sardo, Attilio ; Coppola, Carmela ; Zizolfi, Brunella ; Pastore, Gaetano ; Nappi, Carmine. / Ultrasound assessment of the essure contraceptive devices : Is three-dimensional ultrasound really needed?. In: Journal of Minimally Invasive Gynecology. 2015 ; Vol. 22, No. 1. pp. 115-121.
@article{19e4fb3143b3426aa4fde2c69e4b57f2,
title = "Ultrasound assessment of the essure contraceptive devices: Is three-dimensional ultrasound really needed?",
abstract = "Study Objective: To evaluate the feasibility of 3-dimensional ultrasound (3DUS) for sonographic localization of Essure microinserts, comparing it with 2-dimensional ultrasound (2DUS) insofar as time to visualize the inserts and accuracy in determining their localization. Design: Prospective study (Canadian Task Force classification II-2). Setting: University clinic. Patients: Twenty-seven consecutive women undergoing hysteroscopic Essure device placement. Interventions: Essure microinserts were inserted in the outpatient hysteroscopy clinic following the manufacturer's recommendations, leaving from 3 to 8 loops of the inserts in the uterine cavity. In all patients, 2DUS and 3DUS were performed 3months after the procedure. 2DUS was performed first; the device(s) were located, and their position was recorded. Then 3DUS scans were acquired, trying when possible to have both devices at least at a 45-degree angle withthe insonation beam for optimal rendering on 3DUS. The OmniView method with volume contrast imaging was used to show the relationships of the microinserts within the uterine cavity when possible. To define the position of the Essure device in relation to the uterus and the salpinges, we used the classification developed by Legendre and colleagues. After sonographic evaluation all women underwent hysterosalpingography to assess the success of sterilization. Measurements and Main Results: Hysteroscopic insertion was successful in all patients, with 2 Essure devices placed in 25 patients and 1 device in 2 patients (due to previous salpingectomy performed because of ectopic pregnancy), for a total of 52 devices. One spontaneous late (within 3months) expulsion of the device occurred; the device had migrated almost completely into the uterine cavity. At 3-month follow-up, all 51 correctly placed devices were easily observed at 2DUS (mean [SD] duration of the procedure, 2.25 [0.8] minutes). At 3DUS in 51 cases, the device was in perfect position (1+2+3) in 21 (41.2{\%}), in position 2+3 in 14 (27.4{\%}), and in position +3 in 16 (31.4{\%}). Both microinserts were observed on 3DUS reconstructed images in 31 of 35 (88.6{\%}) 1+2+3 and 2+3 cases. However, in the 16 cases in which the devices were in position +3 (salpinx only), a single 3D sweep failed to demonstrate both devices in 10 of 16 cases (62.5{\%}), due to substantially different angles of orientation of the inserts. This was because if 1 of the 2 devices was placed at a",
keywords = "Essure microinserts, Hysteroscopy, Three-dimensional ultrasound, Two-dimensional ultrasound",
author = "Dario Paladini and {Di Spiezio Sardo}, Attilio and Carmela Coppola and Brunella Zizolfi and Gaetano Pastore and Carmine Nappi",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.jmig.2014.08.010",
language = "English",
volume = "22",
pages = "115--121",
journal = "Journal of Minimally Invasive Gynecology",
issn = "1553-4650",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Ultrasound assessment of the essure contraceptive devices

T2 - Is three-dimensional ultrasound really needed?

AU - Paladini, Dario

AU - Di Spiezio Sardo, Attilio

AU - Coppola, Carmela

AU - Zizolfi, Brunella

AU - Pastore, Gaetano

AU - Nappi, Carmine

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Study Objective: To evaluate the feasibility of 3-dimensional ultrasound (3DUS) for sonographic localization of Essure microinserts, comparing it with 2-dimensional ultrasound (2DUS) insofar as time to visualize the inserts and accuracy in determining their localization. Design: Prospective study (Canadian Task Force classification II-2). Setting: University clinic. Patients: Twenty-seven consecutive women undergoing hysteroscopic Essure device placement. Interventions: Essure microinserts were inserted in the outpatient hysteroscopy clinic following the manufacturer's recommendations, leaving from 3 to 8 loops of the inserts in the uterine cavity. In all patients, 2DUS and 3DUS were performed 3months after the procedure. 2DUS was performed first; the device(s) were located, and their position was recorded. Then 3DUS scans were acquired, trying when possible to have both devices at least at a 45-degree angle withthe insonation beam for optimal rendering on 3DUS. The OmniView method with volume contrast imaging was used to show the relationships of the microinserts within the uterine cavity when possible. To define the position of the Essure device in relation to the uterus and the salpinges, we used the classification developed by Legendre and colleagues. After sonographic evaluation all women underwent hysterosalpingography to assess the success of sterilization. Measurements and Main Results: Hysteroscopic insertion was successful in all patients, with 2 Essure devices placed in 25 patients and 1 device in 2 patients (due to previous salpingectomy performed because of ectopic pregnancy), for a total of 52 devices. One spontaneous late (within 3months) expulsion of the device occurred; the device had migrated almost completely into the uterine cavity. At 3-month follow-up, all 51 correctly placed devices were easily observed at 2DUS (mean [SD] duration of the procedure, 2.25 [0.8] minutes). At 3DUS in 51 cases, the device was in perfect position (1+2+3) in 21 (41.2%), in position 2+3 in 14 (27.4%), and in position +3 in 16 (31.4%). Both microinserts were observed on 3DUS reconstructed images in 31 of 35 (88.6%) 1+2+3 and 2+3 cases. However, in the 16 cases in which the devices were in position +3 (salpinx only), a single 3D sweep failed to demonstrate both devices in 10 of 16 cases (62.5%), due to substantially different angles of orientation of the inserts. This was because if 1 of the 2 devices was placed at a

AB - Study Objective: To evaluate the feasibility of 3-dimensional ultrasound (3DUS) for sonographic localization of Essure microinserts, comparing it with 2-dimensional ultrasound (2DUS) insofar as time to visualize the inserts and accuracy in determining their localization. Design: Prospective study (Canadian Task Force classification II-2). Setting: University clinic. Patients: Twenty-seven consecutive women undergoing hysteroscopic Essure device placement. Interventions: Essure microinserts were inserted in the outpatient hysteroscopy clinic following the manufacturer's recommendations, leaving from 3 to 8 loops of the inserts in the uterine cavity. In all patients, 2DUS and 3DUS were performed 3months after the procedure. 2DUS was performed first; the device(s) were located, and their position was recorded. Then 3DUS scans were acquired, trying when possible to have both devices at least at a 45-degree angle withthe insonation beam for optimal rendering on 3DUS. The OmniView method with volume contrast imaging was used to show the relationships of the microinserts within the uterine cavity when possible. To define the position of the Essure device in relation to the uterus and the salpinges, we used the classification developed by Legendre and colleagues. After sonographic evaluation all women underwent hysterosalpingography to assess the success of sterilization. Measurements and Main Results: Hysteroscopic insertion was successful in all patients, with 2 Essure devices placed in 25 patients and 1 device in 2 patients (due to previous salpingectomy performed because of ectopic pregnancy), for a total of 52 devices. One spontaneous late (within 3months) expulsion of the device occurred; the device had migrated almost completely into the uterine cavity. At 3-month follow-up, all 51 correctly placed devices were easily observed at 2DUS (mean [SD] duration of the procedure, 2.25 [0.8] minutes). At 3DUS in 51 cases, the device was in perfect position (1+2+3) in 21 (41.2%), in position 2+3 in 14 (27.4%), and in position +3 in 16 (31.4%). Both microinserts were observed on 3DUS reconstructed images in 31 of 35 (88.6%) 1+2+3 and 2+3 cases. However, in the 16 cases in which the devices were in position +3 (salpinx only), a single 3D sweep failed to demonstrate both devices in 10 of 16 cases (62.5%), due to substantially different angles of orientation of the inserts. This was because if 1 of the 2 devices was placed at a

KW - Essure microinserts

KW - Hysteroscopy

KW - Three-dimensional ultrasound

KW - Two-dimensional ultrasound

UR - http://www.scopus.com/inward/record.url?scp=84920573483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920573483&partnerID=8YFLogxK

U2 - 10.1016/j.jmig.2014.08.010

DO - 10.1016/j.jmig.2014.08.010

M3 - Article

VL - 22

SP - 115

EP - 121

JO - Journal of Minimally Invasive Gynecology

JF - Journal of Minimally Invasive Gynecology

SN - 1553-4650

IS - 1

ER -